Medicamen Biotech shareholding pattern

MEDICAMEQ

HealthcareSmall

353

0.00 (0.00%)
Last updated on 18 Aug, 2025 | 15:29 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Medicamen Biotech Shareholding Pattern

  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2024-25
  • 2025-26
  • 2023-24
Total Promoters
Segment
Percent

Total Promoters

42.99%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0.06%

Domestic Institutional Investors

0.92%

Retail

56.04%

Others

-0.01%

Total Promoters
MAR '24
43.21%
JUN '24
42.99%
SEP '24
42.99%
DEC '24
42.99%

Medicamen Biotech FAQs

As of 08-2025, the promoter shareholding in Medicamen Biotech stands at 40.46% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Medicamen Biotech is 0% and 0.69% respectively.

The retail shareholding of the Medicamen Biotech is 58.84%.

Changes in shareholding patterns of Medicamen Biotech can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Medicamen Biotech are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.